Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion type Assertion NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_head.
- NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_provenance.
- NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion evidence source_evidence_literature NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_provenance.
- NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion SIO_000772 19752219 NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_provenance.
- NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion wasDerivedFrom befree-20140225 NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_provenance.
- NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_assertion wasGeneratedBy ECO_0000203 NP194807.RASQuEQBp4cD-jrGMHDHMFmREt_7iN6fUHX2Up0zgBxho130_provenance.